Legend Biotech (LEGN) Short term Debt (2025 - 2026)

Legend Biotech (LEGN) has 4 years of Short term Debt data on file, last reported at $266.0 million in Q1 2026.

• Quarterly Short term Debt changed N/A year-over-year to $266.0 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $266.0 million (changed N/A YoY) and the FY2025 annual result came in at $319.1 million, changed N/A from the prior year.
• Short term Debt eased to $266.0 million in Q1 2026, from $319.1 million in the prior quarter.
• In the past five years, Short term Debt ranged from a high of $319.1 million in Q4 2025 to a low of $126.7 million in Q1 2022.
• A 3-year average of $213.7 million and a median of $204.4 million in 2025 frame the typical range for Short term Debt.